Event Gaps: DeepSeek's picks for 2026-10-23
DeepSeek picked DECK, CCI, AMT, SKYD, NCLH for a 1-day horizon. Intraday alpha vs SPY: -1.56%. Picks with positive alpha: 20%.
| Experiment | Event Gaps |
|---|---|
| Model | DeepSeek |
| Prompt version | event-gap-v13 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-23 |
| Measured to | 2026-10-26 |
| Benchmark | SPY |
| Status | Settled |
| Intraday alpha vs SPY | -1.56% |
| Picks with positive alpha | 20% |
| Benchmark return | +0.64% |
The picks
| Rank | Symbol | Gap direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | DECK | +0.59% | -0.59% | 78% | -1.24% | No | |
| 2 | CCI | +1.92% | +1.92% | 74% | +1.28% | Yes | |
| 3 | AMT | +0.13% | +0.13% | 70% | -0.51% | No | |
| 4 | SKYD | -3.29% | -3.29% | 65% | -3.93% | No | |
| 5 | NCLH | +2.78% | -2.78% | 62% | -3.42% | No |
The model's market view
The October 23 session is defined by two competing forces: a broad risk-off tone in technology and high-multiple names, and sharp single-stock reactions to earnings, analyst actions and the SpaceX cell-site story. Deckers and Norwegian Cruise Line face fresh company-specific headwinds, while Crown Castle, American Tower and Skydance carry positive catalysts that are still being digested. I expect dispersion to remain wide, with the strongest moves coming from names where the catalyst directly changes near-term expectations rather than merely reflecting sentiment.
Why each pick
DECK
Deckers lowered its full-year revenue outlook after reporting a rare sales miss in fiscal Q2, its first in at least five years, and Piper Sandler downgraded the stock to Underweight with a $75 target. The catalyst is substantive and directly changes near-term business expectations, not just sentiment. The stock closed at $85.28 on October 22, near the lower end of its recent range, and is trading at $80.14 at 11:10 AM EDT on October 23, down 6.03%, confirming that sellers remain in control. Volume has been elevated, with 8.1 million shares traded on October 22 versus a 20-day average of roughly 2.9 million, which supports the view that institutional selling is driving the move rather than a thin-volume blip. The strongest counter-evidence is that the stock is already near its 52-week low of $77.20 and deeply oversold, so a sharp relief bounce is possible. Invalidation for the down thesis is a close above the October 22 high of $87.92, which would fill the earnings gap and signal that the downgrade has been absorbed. Price history: October 16–22 daily bars show a steady drift lower from $85.71 to $85.28, with a spike in volume on October 22. The 20-day high is $88.40 and the 20-day low is $77.20. The 5-day return is approximately -1.5% and the 20-day average volume is about 2.9 million shares.
CCI
Crown Castle is surging on a Bloomberg report that SpaceX is in active discussions to secure access to roughly 80,000 U.S. cell sites, with Crown Castle identified as one of the tower operators in direct talks. The catalyst is event-driven and speculative because no definitive agreement has been signed, but it is substantive because a SpaceX national wireless buildout would materially increase tenant demand across Crown Castle's tower portfolio. The stock closed at $78.83 on October 22 and is trading at $86.74 at 11:13 AM EDT on October 23, up 10.03%, holding near its session high of $91.45. Volume is already 7.6 million shares versus a 20-day average of about 4.0 million, confirming genuine institutional participation. The main risk is headline reversal: if the SpaceX talks stall or another tower operator is chosen first, the event premium could compress quickly. A secondary risk is that REITs are sensitive to rates. Invalidation for the long thesis is a close back below the October 22 high of $80.40, which would erase the SpaceX gap. Price history: the stock had been range-bound between roughly $65 and $82 before the October 23 gap, and the 20-day high is $82.72 with a 20-day low of $65.32. The 5-day return is approximately +2.8% and the 20-day average volume is about 4.0 million shares.
AMT
American Tower is the second liquid tower REIT benefiting from the same SpaceX cell-site story. The company operates roughly 41,764 sites across the U.S. and Canada, making it a natural counterparty for a nationwide SpaceX network even though Crown Castle has been more directly named in press reports. The stock closed at $181.57 on October 22 and is trading at $190.33 at 11:12 AM EDT on October 23, up 4.82%, after opening at $200.72 and pulling back. The catalyst is substantive but speculative in the sense that the SpaceX talks are not definitive. The main risk is that AMT reports Q3 earnings on October 27, so some investors may de-risk ahead of the print, and a denial of the SpaceX story could quickly erase the gain. Invalidation for the long thesis is a close back below the October 22 high of $182.78, which would erase the SpaceX gap. Price history: the stock had been consolidating between roughly $177 and $186 before the October 23 gap, and the 20-day high is $186.00 with a 20-day low of $160.30. The 5-day return is approximately +1.2% and the 20-day average volume is about 3.1 million shares.
SKYD
Skydance was upgraded by JPMorgan to Neutral from Underweight, with the firm noting that the Warner acquisition creates a media company larger by revenue than Netflix and Disney excluding parks. The catalyst is an analyst action rather than a fundamental change, but it is substantive because it removes a persistent overhang and may prompt other sell-side revisions. The stock closed at $7.79 on October 22 and is trading at $7.82 at 11:13 AM EDT on October 23, up 0.39%, which is a muted reaction relative to the size of the upgrade. The main risk is that the stock is highly volatile and has repeatedly failed to hold rallies; it traded above $10 in early October before sliding to the current level. Invalidation for the up thesis is a close below the October 20 low of $6.87, which would signal that the upgrade has been fully faded. Price history: the stock has been in a downtrend from above $10 in early October to the current $7.80 area, with the 20-day high at $10.42 and the 20-day low at $6.61. The 5-day return is approximately +13% and the 20-day average volume is about 22.5 million shares.
NCLH
Norwegian Cruise Line was downgraded by JPMorgan to Underweight from Neutral with a price target cut to $11 from $13, ahead of the Q3 report. The firm sees an inline quarter but downside risk to second-half 2027 net yield estimates. The catalyst is substantive because it directly lowers the earnings and valuation bar, and it comes just before the company reports. The stock closed at $15.54 on October 22 and is trading at $14.98 at 11:13 AM EDT on October 23, down 3.6%, confirming that sellers are acting on the downgrade. Volume is elevated at 9.4 million shares versus a 20-day average of about 17.6 million, though this is a partial session. The main risk is that the stock is already down sharply from its 2026 highs and could see a relief rally if the Q3 report beats the lowered bar. Invalidation for the down thesis is a close above the October 22 high of $15.80, which would signal that the downgrade has been absorbed. Price history: the stock has been trending lower from above $15.60 in mid-October to the current $15 area, with the 20-day high at $16.14 and the 20-day low at $14.17. The 5-day return is approximately -3.8% and the 20-day average volume is about 17.6 million shares.
Other models on the same run
| Model | Picks | Intraday alpha vs SPY | Picks with positive alpha |
|---|---|---|---|
| GPT-6 | MRNA, WDC, LRCX, SLB, ALLE | -2.21% | 0% |
| Claude Opus 5.5 | GGG, ALLE, CRS, DECK, MRNA | -1.40% | 20% |
| Gemini 3 Pro | CCI, TSLA, TXN, IBM, T | +1.92% | 100% |
| Grok 4.7 | AXP, SLB, VZ, BAH, META | -3.19% | 20% |
| Muse Spark 1.1 | ROP, ALLE, POOL, TTMI, CRS | +2.03% | 60% |
Written up on ForecastNest Insights: Event Gaps: DeepSeek's picks for 2026-10-23.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.